Invention Grant
- Patent Title: Polymorphic forms of deferasirox (ICL670A)
- Patent Title (中): 去甲肾上腺素的多形态（ICL670A）
-
Application No.: US13405428Application Date: 2012-02-27
-
Publication No.: US08436030B2Publication Date: 2013-05-07
- Inventor: Michael Mutz
- Applicant: Michael Mutz
- Applicant Address: CH Basel
- Assignee: Navartis AG
- Current Assignee: Navartis AG
- Current Assignee Address: CH Basel
- Agent Gregory Houghton
- Priority: EP06125002 20061129; EP07112795 20070719
- Main IPC: A61K31/4196
- IPC: A61K31/4196 ; C07D249/08
Abstract:
The invention relates to crystalline forms of 4-[3,5-bis(2-hydroxyphenyl)-[1,2,4]triazol-1-yl]benzoic acid and to its amorphous form, to processes for the preparation thereof, to compositions containing the same and their uses for the manufacture of a medicament for the treatment of the human body.
Public/Granted literature
- US20120203007A1 POLYMORPHIC FORMS OF DEFERASIROX (ICL670A) Public/Granted day:2012-08-09
Information query
